X-linked lymphoproliferative syndrome: An X-cellent question

Clinical Immunology

Volumn 119, Issue 3, 2006, Pages 241-244

  Filipovich, Alexandra ^a   Conley, Mary Ellen ^b   Nichols, Kim E ^c   Sullivan, Kathleen E ^c  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^c CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

EBV; Hemophagocytic lymphohistiocytosis; Hypogammaglobulinemia; X linked lymphoproliferative syndrome

Indexed keywords

ANTIBIOTIC AGENT; IMMUNOGLOBULIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; VIRUS DNA;

ADOLESCENT; ADULT; ANTIBIOTIC THERAPY; ARTICLE; B LYMPHOCYTE; BLOOD TRANSFUSION; BONE MARROW SUPPRESSION; BURKITT LYMPHOMA; CHILD; CLINICAL ARTICLE; CLINICAL EXAMINATION; CLINICAL FEATURE; COMMON VARIABLE IMMUNODEFICIENCY; DISEASE ASSOCIATION; EPSTEIN BARR VIRUS; FEVER; HEPATITIS; HERPES VIRUS INFECTION; HUMAN; HYPERIMMUNOGLOBULINEMIA M; HYPOGAMMAGLOBULINEMIA; IMMUNOGLOBULIN BLOOD LEVEL; INFECTION; INFECTION COMPLICATION; INTESTINE LYMPHOMA; LYMPHOCYTE COUNT; LYMPHOMA; LYMPHOPROLIFERATIVE DISEASE; MALE; MONONUCLEOSIS; NECK TUMOR; PANCYTOPENIA; PNEUMONIA; PRIORITY JOURNAL; RECURRENT INFECTION; T LYMPHOCYTE; X CHROMOSOME LINKED DISORDER; X LINKED LYMPHOPROLIFERATIVE SYNDROME;

ADOLESCENT; ADULT; ALLERGY AND IMMUNOLOGY; CHILD; CHILD, PRESCHOOL; CONSENSUS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; LYMPHOPROLIFERATIVE DISORDERS; MALE; PHENOTYPE; PHYSICIANS;

EID: 33646389544     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2006.02.005     Document Type: Article

References (22)

1. Eastwood D., Gilmour K.C., Nistala K., Meaney C., Chapel H., Sherrell Z., Webster A.D., Davies E.G., Jones A., and Gaspar H.B. Prevalence of SAP gene defects in male patients diagnosed with common variable immunodeficiency. Clin. Exp. Immunol. 137 3 (2004) 584-588
2. Sumazagi R., Kanegane H., Osaki M., Fukushima T., Tsuchida M., Matsukura H., Shinozaki K., Kimura H., Matsui A., and Miyawaki T. SH2D1A mutations in Japanese males with severe Epstein Barr virus-associated illnesses. Blood 98 4 (2001) 1268-1270
3. Tabata Y., Villanueva J., Molleran L.S., Zhang K., Kanegane H., Miyawaki T., Sumegi J., and Filipovich A.H. Rapid detection of intracellular SH2D1A protein in cytotoxic lymphocytes from patients with X-linked lymphoproliferative disease and their family members. Blood 105 8 (2005) 3066-3071
4. Bar R.S., DeLor C.J., Clausen K.P., Hurtubise P., Henle W., and Hewetson J.F. Fatal infectious mononucleosis in a family. N. Engl. J. Med. 290 (1974) 363-367
5. Purtilo D.T., Cassel C.K., Yang J.P., and Harper R. X-linked recessive progressive combined variable immunodeficiency (Duncan's disease). Lancet 1 (1975) 935-940
6. Purtilo D.T., DeFlorio D.J., Hutt L.M., Bhawan J., Yang J.P., Otto R., and Edwards W. Variable phenotypic expression of an X-linked recessive lymphoproliferative syndrome. N. Engl. J. Med. 297 (1977) 1077-1080
7. Grierson H., and Purtilo D.T. Epstein-Barr virus infections in males with the X-linked lymphoproliferative syndrome. Ann. Intern. Med. 106 (1987) 538-545
8. Sayos J., Wu C., Morra M., Wang N., Zhang X., Allen D., van Schaik S., Notarangelo L., Geha R., Roncarolo M.G., Oettgen H., de Vries J.E., Aversa G., and Terhorst C. The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM. Nature 395 (1998) 462-469
9. Coffey A.J., Brooksbank R.A., Brandau O., Oohashi T., Howell G.R., Bye J.M., Cahn A.P., Durham J., Heath P., Wray P., Pavitt R., Wilkinson J., Leversha M., Huckle E., Shaw-Smith C.J., Dunham A., Rhodes S., Schuster V., Porta G., Yin L., Serafini P., Sylla B., Zollo M., Franco B., and Bentley D.R. Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene. Nat. Genet. 20 (1998) 129-135
10. Nichols K.E., Harkin D.P., Levitz S., Krainer M., Kolquist K.A., Genovese C., Bernard A., Ferguson M., Zuo L., Snyder E., Buckler A.J., Wise C., Ashley J., Lovett M., Valentine M.B., Look A.T., Gerald W., Housman D.E., and Haber D.A. Inactivating mutations in an SH2 domain-encoding gene in X-linked lymphoproliferative syndrome. Proc. Natl. Acad. Sci .U. S. A. 95 (1998) 13765-13770
11. Sumegi J., Seemayer T.A., Huang D., Davis J.R., Morra M., Gross T.G., Yin L., Romco G., Klein E., Terhorst C., and Lanyi A. A spectrum of mutations in SH2D1A that causes X-linked lymphoproliferative disease and other Epstein-Barr virus-associated illnesses. Leuk. Lymphoma 43 (2002) 1189-1201
12. Menasche G., Feldmann J., Fischer A., and de Saint B.G. Primary hemophagocytic syndromes point to a direct link between lymphocyte cytotoxicity and homeostasis. Immunol. Rev. 203 (2005) 165-179
13. Purtilo D.T., Sakamoto K., Barnabei V., Seeley J., Bechtold T., Rogers G., Yetz J., and Harada S. Epstein-Barr virus-induced diseases in boys with the X-linked lymphoproliferative syndrome (XLP): update on studies of the registry. Am. J. Med. 73 (1982) 49-56
14. Levy J., Espanol-Boren T., Thomas C., Fischer A., Tovo P., Bordigoni P., Resnick I., Fasth A., Baer M., Gomez L., Sanders E.A., Tabone M.D., Plantaz D., Etzioni A., Monafo V., Abinun M., Hammarstrom L., Abrabamsen T., Jones A., Finn A., Klemola T., DeVries E., Sanal O., Peitsch M.C., and Notarangelo L.D. Clinical spectrum of X-linked hyper-IgM syndrome. J. Pediatr. 131 (1997) 47-54
15. Winkelstein J.A., Marino M.C., Ochs H., Fuleihan R., Scholl P.R., Geha R., Stiehm E.R., and Conley M.E. The X-linked hyper-IgM syndrome: clinical and immunologic features of 79 patients. Medicine (Baltimore) 82 (2003) 373-384
16. Tabata Y., Villanueva J., Lee S.M., Zhang K., Kanegane H., Miyawaki T., Sumegi J., and Filipovich A.H. Rapid detection of intracellular SH2D1A protein in cytotoxic lymphocytes from patients with X-linked lymphoproliferative disease and their family members. Blood 105 (2005) 3066-3071
17. Purtilo D.T., Cassel C.K., Yang J.P.S., Harper P., Stephensen S.R., Landing B.H., and Vawter G.F. X-linked recessive progressive combined variable immunodeficiency (Duncan's disease). Lancet 1 (1975) 935-941
18. Nichols K.E., Ma C.S., Cannons J., Schwartzberg P.L., and Tangye S.G. Molecular and cellular pathogenesis of X-linked lymphoproliferative disease. Immunol. Rev. 203 (2005) 180-199
19. Milone M., Tsai D.E., Hodinka R., Silverman L.B., Stadtmauer E.A., Malbran A., Wasik M., and Nichols K.E. Use of B-cell directed therapy to treat primary Epstein-Barr virus (EBV) infection in patients with X-linked lymphoproliferative disease (XLP). Blood 105 (2005) 994-996
20. http://www.genetests.org/.
21. Nichols K.E., Hom J., Gong S.-Y., Ganguly A., Ma C., Cannons J., Tangye S.G., Schwartzberg P.L., Koretzky G.A., and Stein P.L. Regulation of NKT cell development by SAP, the protein defective in X-linked lymphoproliferative disease. Nat. Med. 11 (2005) 340-345
22. + T cells. J. Clin. Invest. 115 (2005) 1049-1059